Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Food and Drug Administration Safety and Innovation Act (FDASIA)

Food and Drug Administration Safety and Innovation Act (FDASIA)

                        FDASIA Title VII Drug Supply Chain Provisions
          FDASIA Title VII Overview
          FDASIA Section 907: Inclusion of Demographic Subgroups in Clinical Trials Home
          Regulatory Information
          Laws Enforced by FDA
          Selected Amendments to the FD&C Act
          Food and Drug Administration Safety and Innovation Act (FDASIA)
          FDASIA Section 705 Annual ReportsFood and Drug Administration Safety and Innovation Act (FDASIA) FDASIA Section 705 Annual Reports
  
  	
    Share
    Post
    Linkedin

    Email
    Print**Annual Reports on Inspections of Establishments**
Section 705 of the Food and Drug Administration Safety and Innovation Act (FDASIA) requires FDA to publish annual reports on its website that include the number and type of registered establishments inspected and the percentage of the FDA budget used to fund such inspections.

FDASIA 705 CY 2022 Annual Report on Inspections of Establishments
	This year’s report aligns with the statutory charge given by Congress in FD&C Act section 510(h)(6)(C), which changed the reporting requirement from fiscal year (FY) to Calendar Year (CY).
	FDASIA 705 CY 2021 Annual Report on Inspections of Establishments
	This year’s report aligns with the statutory charge given by Congress in FD&C Act section 510(h)(6)(C), which changed the reporting requirement from fiscal year (FY) to Calendar Year (CY).
	FDASIA 705 CY 2020 Annual Report on Inspections of Establishments
	The statutory requirement for publishing this report is May 1st; however, the report was held for release in tandem with the Resiliency Report.
	This year’s report aligns with the statutory charge given by Congress in FD&C Act section 510(h)(6)(C), which changed the reporting requirement from fiscal year (FY) to Calendar Year (CY).
	FDASIA 705 CY 2019 Annual Report on Inspections of Establishments
	This year’s report aligns with the statutory charge given by Congress in FD&C Act section 510(h)(6)(C), which changed the reporting requirement from fiscal year (FY) to Calendar Year (CY).
	CY 2018 Annual Report on Inspection of Establishments Report
	This year’s report aligns with the statutory charge given by Congress in FD&C Act section 510(h)(6)(C), which changed the reporting requirement from fiscal year (FY) to Calendar Year (CY).
	CY 2017 Annual Report on Inspection of Establishments Report
	This year’s report aligns with the statutory charge given by Congress in FD&C Act section 510(h)(6)(C), which changed the reporting requirement from fiscal year (FY) to Calendar Year (CY).
	2017 Annual Report
	2016 Annual Report
	2015 Annual Report
	2014 Annual Report

                                                                                  Content current as of:
      04/27/2022
              
              
Regulated Product(s)
		 Animal & Veterinary
			  			     			  			     Biologics
			     			  			     Drugs
			     			  			     Medical DevicesLaw(s) & Regulation(s)
			  FDA Safety and Innovation Act (FDASIA)Food and Drug Administration Safety and Innovation Act (FDASIA)

          
                        FDASIA Title VII Drug Supply Chain Provisions
          FDASIA Title VII Overview
          FDASIA Section 907: Inclusion of Demographic Subgroups in Clinical Trials
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop